Bausch Health’s Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026

LAVAL, QC, Nov. 6, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, will

1 sources · 1 articles · updated 2026-11-06 12:04 UTC · general

Coverage

1. Bausch Health’s Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026

   National Post · 2026-11-06 12:04 UTC

   LAVAL, QC, Nov. 6, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, will

   Summary on nerom.app